AGIOAgios Pharmaceuticals, Inc.
$31.83-16% 1Y
$31.83
$22.3452 weeks$45.49
Is the price fair?
What AGIO's price assumes
Agios Pharmaceuticals, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 39.9× revenue.
39.9
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 1.80
Price / book · today's price, fiscal year to Dec 31, 2025
- EV / sales
- 24.0
EV / sales
Details›
- Price / booktoday's price, fiscal year to Dec 31, 2025
- 1.80
- EV / EBIToperating margin −467%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, fiscal year to Dec 31, 2025
- 24.0
- Market capitalisation
- $2.15B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks